Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients: LANTU_C_02761 (NCT00751114) Extension Trial
| Status: | Archived |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2009 |
| End Date: | September 2011 |
Combination Therapy of Insulin Glargine and Sitagliptin in Patients With Type 2 Diabetes Not Adequately Controlled by a Previous Treatment With Metformin and Either Insulin Glargine or Sitagliptin
The objectives of this study are:
- To assess the glycemic control (HbA1c <7%) of a 3-month combination therapy with
metformin, insulin glargine and sitagliptin in patients not adequately controlled by a
previous treatment with metformin plus either insulin glargine or sitagliptin.
- To assess the effect of insulin glargine in combination with sitagliptin on HbA1c
level, Fasting Plasma Glucose, 7-point glucose profile, Hypoglycemia occurrence, Body
weight and overall safety.
We found this trial at
1
site
Click here to add this to my saved trials
